- Generic name
- Esomeprazole
- Strength
- 40 mg
- Dosage form
- Capsule
- Manufactured by
- Globe Pharmaceuticals Ltd.
Ema-40 Capsule
About Ema-40 Capsule
Made by Globe Pharmaceuticals Ltd., Ema-40 is a capsule whose active ingredient is Esomeprazole. In people with duodenal ulcer disease, it may be combined with amoxicillin and clarithromycin to clear Helicobacter pylori infection.
There are 161 brands of Esomeprazole listed in Bangladesh. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.
What is Ema-40 Capsule?
Ema-40 comes as a capsule with 40 mg of Esomeprazole, from Globe Pharmaceuticals Ltd. This medicine lowers the amount of acid your stomach produces. This helps relieve symptoms like heartburn and allows irritated areas in the food pipe to heal. Your doctor will decide how long you need it.
Uses of Ema-40
In people with duodenal ulcer disease, it may be combined with amoxicillin and clarithromycin to clear Helicobacter pylori infection. Ema-40 40 mg capsule is used to relieve chronic heartburn and other symptoms of gastroesophageal reflux disease (GERD). It helps heal erosive esophagitis and can be continued to keep it healed. Your doctor will determine if this medicine is appropriate for your specific condition.
How to use Ema-40
If you have difficulty swallowing, the capsule may be opened and the pellets mixed with a spoonful of soft, non-hot applesauce and swallowed straight away without chewing. Swallow the capsule whole with water. Ema-40 is taken by mouth. Take Ema-40 exactly as your doctor prescribes. Complete the course exactly as prescribed. The doctor decides the dose and how long the course lasts; never adjust these yourself.
Side effects of Ema-40
If any effect bothers you, is severe, or does not settle, contact your doctor. Your doctor or pharmacist can give you more information about side effects. Ask the doctor or pharmacist about anything you are unsure of, and seek medical help promptly for serious symptoms. Ask your doctor before taking other medicines alongside it. Ask your doctor or pharmacist what to do if a side effect bothers you.
Safety and precautions
Breastfeeding should be discontinued if this medicine is essential. A response to this medicine does not rule out a more serious stomach problem, so persistent symptoms need medical review. There are no adequate studies in pregnant women, and it is not known whether Esomeprazole passes into breast milk; breastfeeding should be stopped if the medicine is considered essential. Keep out of reach of children.
Frequently asked questions
What is Ema-40 used for?
In people with duodenal ulcer disease, it may be combined with amoxicillin and clarithromycin to clear Helicobacter pylori infection. Ema-40 40 mg capsule is used to relieve chronic heartburn and other symptoms of gastroesophageal reflux disease (GERD).
How is Ema-40 used?
If you have difficulty swallowing, the capsule may be opened and the pellets mixed with a spoonful of soft, non-hot applesauce and swallowed straight away without chewing. Swallow the capsule whole with water.
What should I watch for while using Ema-40?
If any effect bothers you, is severe, or does not settle, contact your doctor. Your doctor or pharmacist can give you more information about side effects.
Who should be careful with Ema-40?
Breastfeeding should be discontinued if this medicine is essential. A response to this medicine does not rule out a more serious stomach problem, so persistent symptoms need medical review.
Indications
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease. ... Read more
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
- Zollinger-Ellison Syndrome
- Acid related Dyspepsia
- Duodenal & Gastric ulcer
Pharmacology
Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.
Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.
Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.
Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.
Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.
Dosage & Administration
Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive
Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).
Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.
Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.
Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.
Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.
Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.
Interaction
Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).
Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.
Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.
Overdose Effects
Storage Conditions
Alternative brands of Esomeprazole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.